425 related articles for article (PubMed ID: 27924788)
1. Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review.
Tan P; Zhang C; Wei SY; Tang Z; Gao L; Yang L; Wei Q
Asian J Androl; 2017; 19(6):666-671. PubMed ID: 27924788
[TBL] [Abstract][Full Text] [Related]
2. Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma.
Zhou YY; Zhu GQ; Wang Y; Zheng JN; Ruan LY; Cheng Z; Hu B; Fu SW; Zheng MH
Oncotarget; 2016 Apr; 7(16):21753-62. PubMed ID: 26943041
[TBL] [Abstract][Full Text] [Related]
3. LDL-lowering therapy and the risk of prostate cancer: a meta-analysis of 6 randomized controlled trials and 36 observational studies.
Tan P; Wei S; Tang Z; Gao L; Zhang C; Nie P; Yang L; Wei Q
Sci Rep; 2016 Apr; 6():24521. PubMed ID: 27075437
[TBL] [Abstract][Full Text] [Related]
4. Effect of Statins on the Risk of Different Stages of Prostate Cancer: A Meta-Analysis.
Li Y; Cheng X; Zhu JL; Luo WW; Xiang HR; Zhang QZ; Peng WX
Urol Int; 2022; 106(9):869-877. PubMed ID: 34518476
[TBL] [Abstract][Full Text] [Related]
5. Impact of statin dosing intensity on transaminase and creatine kinase.
Dale KM; White CM; Henyan NN; Kluger J; Coleman CI
Am J Med; 2007 Aug; 120(8):706-12. PubMed ID: 17679130
[TBL] [Abstract][Full Text] [Related]
6. Statins and cancer risk: a meta-analysis.
Dale KM; Coleman CI; Henyan NN; Kluger J; White CM
JAMA; 2006 Jan; 295(1):74-80. PubMed ID: 16391219
[TBL] [Abstract][Full Text] [Related]
7. High-dose statin therapy and risk of intracerebral hemorrhage: a meta-analysis.
Pandit AK; Kumar P; Kumar A; Chakravarty K; Misra S; Prasad K
Acta Neurol Scand; 2016 Jul; 134(1):22-8. PubMed ID: 26647879
[TBL] [Abstract][Full Text] [Related]
8. Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies.
Bonovas S; Filioussi K; Sitaras NM
Int J Cancer; 2008 Aug; 123(4):899-904. PubMed ID: 18491405
[TBL] [Abstract][Full Text] [Related]
9. Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies.
Scosyrev E; Tobis S; Donsky H; Wu G; Joseph J; Rashid H; Messing E
BJU Int; 2013 Mar; 111(3 Pt B):E71-7. PubMed ID: 23017100
[TBL] [Abstract][Full Text] [Related]
10. Statin use and risk of pancreatic cancer: a meta-analysis.
Cui X; Xie Y; Chen M; Li J; Liao X; Shen J; Shi M; Li W; Zheng H; Jiang B
Cancer Causes Control; 2012 Jul; 23(7):1099-111. PubMed ID: 22562222
[TBL] [Abstract][Full Text] [Related]
11. The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis.
Tan P; Wei S; Yang L; Tang Z; Cao D; Liu L; Lei J; Fan Y; Gao L; Wei Q
Sci Rep; 2016 Jul; 6():29106. PubMed ID: 27384548
[TBL] [Abstract][Full Text] [Related]
12. Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies.
Pradelli D; Soranna D; Zambon A; Catapano A; Mancia G; La Vecchia C; Corrao G
Cancer Med; 2015 May; 4(5):770-80. PubMed ID: 25809667
[TBL] [Abstract][Full Text] [Related]
13. Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
Raval AD; Thakker D; Negi H; Vyas A; Kaur H; Salkini MW
Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):151-62. PubMed ID: 26782711
[TBL] [Abstract][Full Text] [Related]
14. Hypertension and risk of prostate cancer: a systematic review and meta-analysis.
Liang Z; Xie B; Li J; Wang X; Wang S; Meng S; Ji A; Zhu Y; Xu X; Zheng X; Xie L
Sci Rep; 2016 Aug; 6():31358. PubMed ID: 27511796
[TBL] [Abstract][Full Text] [Related]
15. 2,3,7,8-Tetrachlorodibezo-p-dioxin exposure and prostate cancer: a meta-analysis of cohort studies.
Leng L; Chen X; Li CP; Luo XY; Tang NJ
Public Health; 2014 Mar; 128(3):207-13. PubMed ID: 24461260
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
17. Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis.
Obasi M; Abovich A; Vo JB; Gao Y; Papatheodorou SI; Nohria A; Asnani A; Partridge AH
Cancer Causes Control; 2021 Dec; 32(12):1395-1405. PubMed ID: 34406595
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies.
Zhang F; Yang Y; Skrip L; Hu D; Wang Y; Wong C; Qiu J; Lei H
Acta Diabetol; 2012 Dec; 49 Suppl 1():S235-46. PubMed ID: 23124624
[TBL] [Abstract][Full Text] [Related]
19. Statin use and risk of new-onset diabetes: A meta-analysis of observational studies.
Casula M; Mozzanica F; Scotti L; Tragni E; Pirillo A; Corrao G; Catapano AL
Nutr Metab Cardiovasc Dis; 2017 May; 27(5):396-406. PubMed ID: 28416099
[TBL] [Abstract][Full Text] [Related]
20. Statins and primary liver cancer: a meta-analysis of observational studies.
Pradelli D; Soranna D; Scotti L; Zambon A; Catapano A; Mancia G; La Vecchia C; Corrao G
Eur J Cancer Prev; 2013 May; 22(3):229-34. PubMed ID: 23010949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
